Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 14
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
Interferon alpha Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jan/27/2021 5 1
Oseltamivir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/11/2020 5 3
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 3 0
MLN-3897 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0